Guardianship Regulation 2026
10Major medical treatment
Start here
Get a plain-English read of 10
Turn the raw legal text into a practical explanation grounded in Guardianship Regulation 2026.
10 Major medical treatment
10 Major medical treatment
(1) For the Act, section 33(1), definition of major treatment, the following medical treatment, not including special treatment, is declared to be major treatment—
(a) treatment involving the administration of a long-acting injectable hormonal substance for the purpose of contraception or menstrual regulation,
Example—
medroxyprogesterone acetate, in suspension, commonly known as Depo-Provera
(b) treatment involving the administration of a drug of addiction,
(c) treatment involving the administration of a general anaesthetic,
(d) treatment involving the administration of sedation, but not treatment involving—
(i) sedation used to facilitate the management of fractured or dislocated limbs, or
(ii) sedation used to facilitate the insertion of an endoscope into a patient’s body for diagnostic purposes, unless the endoscope is inserted through a breach or incision in the skin or a mucous membrane,
(e) treatment used to eliminate menstruation,
(f) treatment involving the administration of a restricted substance to affect the central nervous system, but not a treatment—
(i) involving a substance intended to be used for analgesic, antipyretic, antiparkinsonian, anticonvulsant, antiemetic, antinauseant or antihistaminic purposes, or
(ii) that will be given only once, or
(iii) that is a PRN treatment given—
(A) when required, and
(B) no more than 3 times a month, or
(iv) given for sedation in minor medical procedures,
(g) treatment involving a substantial risk to the patient, being a risk that amounts to more than a mere possibility of—
(i) death, or
(ii) brain damage, or
(iii) paralysis, or
(iv) permanent loss of function of an organ or limb, or